We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Siemens Celebrates Success of Urine Chemistry Analyzer

By Labmedica staff writers
Posted on 16 Jul 2008
Placement of the 50,000th Clinitek Status urine chemistry analyzer, manufactured by Siemens (Sudbury, UK), was specially marked with a commemorative plaque handed over by Donal Quinn, CEO of Siemens Healthcare Diagnostics, to Lynda Petley, point-of-care manager, Partnership Pathology Services (Frimley, UK) at a ceremony held to mark the occasion.

"This 50,000th placement marks a milestone for Siemens. The Clinitek Status analyzer has been popular amongst customers since launched in November 2003, and continues to be adopted because it fulfils customers' needs for automated, accurate urinalysis readings.” commented Mr. Quinn.

To mark the occasion, a commemorative gold medal was presented to the production site and employees were each given a gold medal. Celebratory events will also take place at the Siemens R&D sites in Elkhart, IN, and Edgewater, MA (USA).

Clinik Status urine analyzers provide important markers to detect early stages of many disease states, such as diabetes, kidney disease, and urinary tract infections. They are used in both secondary and primary care settings. They are robust, simple to use, cost-effective, and provide accurate results transferred in printouts to lab personnel.


Related Links:
Siemens Healthcare Diagnostics
Partnership Pathology Services

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer

Latest Clinical Chem. News

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
16 Jul 2008  |   Clinical Chem.

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
16 Jul 2008  |   Clinical Chem.

Low-Cost Portable Screening Test to Transform Kidney Disease Detection
16 Jul 2008  |   Clinical Chem.